Cell-based therapeutics in Cardiovascular Medicine: From Angiogenesis to Large Vessel Repair

Mark Slevin

“I feel privileged to be working in this exciting field of vascular biology, and to be associated with the journal Vascular Cell as we move towards the point of a critical understanding of mechanisms of blood vessel formation and function. Armed with this information, and coupled with expertise from multidisciplinary fields such as nano-medicine, genetic engineering and tissue imaging, over the next decade, we should be able to introduce effective new clinical therapies targeting the major angiogenic diseases, which include cancer, heart disease and stroke.”

Yihai Cao

“Being an expert in vascular biology, I feel extremely privileged and excited to serve the scientific community as one of the Editors-in-Chief of Vascular Cell . Vascular biology is one of the most exciting and fast-expanding areas in biomedical research. It covers almost all areas in medical research and has cross-disciplinary clinical implications for the treatment of most common and lethal human diseases including cancer, cardiovascular disease and metabolic disease. Our goal is to launch Vascular Cell as one of the most authoritative journals in the field of vascular biology by publishing high-quality papers across the entire vascular biology area, with particular emphasis on translational research in this area. Together with Professors Slevin and Kitajewski, I look forward to serving the scientific community by reporting your groundbreaking discoveries in this high-impact journal.”

Jan Kitajewski

“Today, there are unprecedented opportunities to utilize model systems to better understand the construction and pathologies of the vasculature, and to translate this knowledge to improve human health. We will strive to develop Vascular Cell as a home for reporting on timely research discoveries that shine a light on the vasculature in health and disease.”